spacer
home > ict > autumn 2009 > low impact trials
PUBLICATIONS
International Clinical Trials

Low Impact Trials

 

Clinical trials can have a considerable impact on the environment, particularly when it comes to packaging and transportation. With medical companies increasingly keen to improve their green credentials, many are now looking for ways to increase the efficiency and sustainability of their operations. The benefits of this approach extend beyond corporate social responsibility, potentially reducing the cost of conducting trials internationally.

A good place to start when attempting to reduce the environmental impact of clinical trials is to evaluate the packaging system being used. Developing effective packaging for trial drugs, particularly temperature-sensitive products, is more challenging than ever, with items shipped over increasingly long distances and time-scales, and new legislation being introduced constantly.

Before you can set about trying to make your packaging more environmentally friendly, you need to ensure it fulfils its main function: to protect its contents in storage and distribution, and ensure that they can be delivered to the location of the trial in good condition. This is no easy task, as packaging is commonly subjected to extreme temperatures and hazards such as vibration, moisture, heat, and light penetration. The packaging must be robust and secure, but also compact and lightweight to keep shipping costs down, making the development processes extremely complex.

To achieve a solution that meets all of these criteria, and has minimal effect on the environment, requires the right design and, importantly, the right materials. In the retail and food industries, eco-packaging has become big business. Innovative packaging materials are continually being introduced, produced from sustainable resources, such as crops, or materials that compost or biodegrade easily in a short time period. Some of these latest technologies are now finding their way into other sectors, but it is vital that both the properties of the alternative materials and the specific requirements of the application they are to be used for are properly understood before deciding on a solution.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Geraint Thomas graduated from Brunel University in 1996 with a BSc, First Class Honours in Industrial Product Design. After working as a Board Game Engineer for Hasbro toys, he joined Laminar Medica in 1998 as a Packaging Development Technologist with responsibility for packaging solutions and qualification packages for insulated shipper design. Now employed as Technical Director, Geraint has been instrumental in realising Laminar Medica’s development programme, including the expansion of the company’s qualification laboratory and R&D facility.
spacer
Geraint Thomas
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Symphony Health to provide free access to new Metys COVID-19 Module for U.S. based life sciences industry during pandemic

RALEIGH, N.C., April 08, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today that Symphony Health, a PRA Health Sciences company, will make a 30-day license of its newly released MetysTM COVID-19 Module available to the U.S. life science industry at no charge.
More info >>

White Papers

Medpace Reference Laboratories establishes state of the art Flow Cytometry techniques for flexible approaches to clinical trials across multiple therapeutic areas.

Medpace

Cytometry is the process of measuring the properties of individual cells. These properties may include gene or protein expression, chemical properties, deoxyribonucleic acid (DNA) content, and various cellular functions. The earliest methods of cytometry relied upon light microscopy for the classification and observation of cells and cellular components. Microscopy permitted direct visual observation of cells for the first time, leading to the classification of cells by morphology and insight into cellular functions. However, the time required for microscopic analysis constrains the number of samples or number of cells in each sample that can be examined. Therefore, the utility of microscopy for analysis of rare cells or in situations where sample throughput is a priority is limited. Flow cytometry was developed largely to improve upon these limitations.
More info >>

 
Industry Events

Evolution Summit

20-22 July 2020, The Ritz Carlton, Fort Lauderdale, FL

The 22nd Evolution Summit is the premium forum bringing leading drug development executives and solution providers together. As an invitation-only event, taking place behind closed doors, the Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement